Research and Clinical Trials

Mayo Clinic researchers are collaborating to develop CAR-T cell therapy for solid tumors in thyroid cancer.

Drs. Terry Burns and Alfredo Quiñones-Hinojosa discuss brain tumors called gliomas and the hope being offered by new technology and clinical trials.

Dr. Sujay Vora is studying a new approach to glioblastoma treatment that is improving health outcomes and quality of life for elderly people like Richard Casper.

Dr. S. John Weroha discusses new treatments and research that are helping more people survive ovarian cancer.

Hypothesis-driven AI offers an innovative way to use massive datasets to help discover the complex causes of diseases such as cancer and improve treatment strategies.

People with early-stage triple-negative breast cancer and high levels of immune cells in their tumors may have a lower risk of recurrence and better survival rates.

Richard Vile, Ph.D., is leading research into genetically engineered viruses called oncolytic viruses for cancer treatment at Mayo Clinic.

After receiving CAR-T cell therapy at Mayo Clinic, Welsh-born John Cadwallader achieved remission and found new hope. He now receives care in the U.K. and is monitored by Mayo in the U.S. and London.

After undergoing genetic screening as part of a research study, Tammy LeDoux learned she had Lynch syndrome, which put her at high risk of cancer.

Mayo Clinic launched the Caregiver Support Program to help family caregivers in December 2021. This is its origin story.